These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8463894)

  • 21. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
    Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
    J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland.
    Takala AK; Peltola H; Eskola J
    Laryngoscope; 1994 Jun; 104(6 Pt 1):731-5. PubMed ID: 8196448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.
    Barbour ML; Mayon-White RT; Coles C; Crook DW; Moxon ER
    J Infect Dis; 1995 Jan; 171(1):93-8. PubMed ID: 7798687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine.
    Forleo-Neto E; de Oliveira CF; Maluf EM; Bataglin C; Araujo JM; Kunz LF; Pustai AK; Vieira VS; Zanella RC; Brandileone MC; Mimica LM; Mimica IM
    J Infect Dis; 1999 Oct; 180(4):1153-8. PubMed ID: 10479142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilus influenzae type B conjugate vaccines.
    Force RW; Lugo RA; Nahata MC
    Ann Pharmacother; 1992 Nov; 26(11):1429-40. PubMed ID: 1477450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of conjugated PRP vaccines on the incidence of invasive diseases caused by Haemophilus influenzae Type B in childhood].
    Desgrandchamps D; Schmid R; Zimmermann HP; Imahorn P; Kabus K; Schubiger G
    Schweiz Med Wochenschr; 1994 Apr; 124(14):575-82. PubMed ID: 8184297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemophilus influenzae type b infections in day care attendees: implications for management.
    Daum RS; Granoff DM; Gilsdorf J; Murphy T; Osterholm MT
    Rev Infect Dis; 1986; 8(4):558-67. PubMed ID: 3529311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
    Black SB; Shinefield HR
    Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.
    Singleton R; Hammitt L; Hennessy T; Bulkow L; DeByle C; Parkinson A; Cottle TE; Peters H; Butler JC
    Pediatrics; 2006 Aug; 118(2):e421-9. PubMed ID: 16882783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
    Black SB; Shinefield HR; Fireman B; Hiatt R; Polen M; Vittinghoff E
    Pediatr Infect Dis J; 1991 Feb; 10(2):97-104. PubMed ID: 2062621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
    Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM
    Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children.
    Adegbola RA; Mulholland EK; Secka O; Jaffar S; Greenwood BM
    J Infect Dis; 1998 Jun; 177(6):1758-61. PubMed ID: 9607866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children.
    Takala AK; Santosham M; Almeido-Hill J; Wolff M; Newcomer W; Reid R; Käyhty H; Esko E; Mäkelä PH
    Pediatr Infect Dis J; 1993 Jul; 12(7):593-9. PubMed ID: 8346004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.